Sponsor Pipeline

Jiangsu Alphamab Biopharmaceuticals Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
16
Active Trials
7
Recruiting
3
Phase 3
6
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07617727
A Phase I Study of JSKN021 in Advanced Solid Tumors
Recruitment opened
2026-07-31 NCT07617727
A Phase I Study of JSKN021 in Advanced Solid Tumors
Trial sites expanded: 0 -> 6 locations
Active Trials by Phase
Phase 3
3
Phase 2
3
Phase 1/2
4
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06079983 JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or… Breast Cancer Recruiting
NCT07533123 A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With… Triple Negative Breast Cancer Recruiting
NCT06751485 JSKN003 in Platinum-Resistant, Relapsed Epithelial Ovarian Cancer Ovarian Cancer Not Yet Recruiting
Phase 2
NCT06775483 Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance: a Phase II… Advanced Non-small Cell Lung Cancer Not Yet Recruiting
NCT07283198 A Phase II Clinical Study to Evaluate the Safety, Efficacy… Non Small Cell Lung Cancer (NSCLC) Not Yet Recruiting
NCT07497074 JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer Cervical Cancer Not Yet Recruiting
Phase 1/2
NCT06942234 Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic… Inoperable Locally Advanced HER2-Negative Breast Cancer Recruiting
NCT06770881 JSKN033 in Chinese Subjects with Advanced Malignant Tumors Advanced Malignant Tumors Not Yet Recruiting
NCT07336771 JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive… Metastatic Breast Cancer Not Yet Recruiting
NCT05744427 Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors Advanced Solid Tumor Active, Not Recruiting
Phase 1
NCT06592417 To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced… Advanced Malignant Solid Tumor Recruiting
NCT07292402 JSKN022 in Subjects With Advanced Malignant Solid Tumors Advanced Malignant Solid Tumors Recruiting
NCT06868732 Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC Advanced Non-small Cell Lung Cancer Recruiting
NCT07617727 A Phase I Study of JSKN021 in Advanced Solid Tumors Advanced Malignant Solid Tumors Recruiting
NCT07391644 A Study of JSKN027 in Patients With Advanced Solid Tumors Advanced Malignant Solid Tumor Not Yet Recruiting
NCT07475559 JSKN016HC in Patients With Advanced or Metastatic Solid Malignant Tumors Advanced Solid Tumor Malignancies Not Yet Recruiting
Disease Areas
Get alerts when Jiangsu Alphamab Biopharmaceuticals Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free